Benzinga | May 10, 2021 04:22PM EDT

Arcturus Therapeutics Q1 EPS $(2.15) Misses $(1.25) Estimate, Sales $2.13M Miss $2.54M Estimate

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(2.15) per share which missed the analyst consensus estimate of $(1.25) by 72 percent. This is a 220.9 percent decrease over losses of $(0.67) per share from the same period last year. The company reported quarterly sales of $2.13 million which missed the analyst consensus estimate of $2.54 million by 16.26 percent. This is a 19.61 percent decrease over sales of $2.65 million the same period last year.